Wall Street Analysts Are Bullish on Top Healthcare Picks


There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Acorda Therapeutics (NASDAQ:ACOR) and Applied Genetic Technologies (NASDAQ:AGTC) with bullish sentiments.

Acorda Therapeutics (ACOR)

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Acorda Therapeutics, with a price target of $31. The company’s shares closed yesterday at $20.80.

According to TipRanks.com, Selvaraju is a 3-star analyst with an average return of 2.7% and a 45.5% success rate. Selvaraju covers the Healthcare sector, focusing on stocks such as Biospecifics Technologies Corp, EyePoint Pharmaceuticals Inc, and Bausch Health Companies Inc.

Currently, the analyst consensus on Acorda Therapeutics is a Moderate Buy with an average price target of $26.71.

See today’s analyst top recommended stocks >>

Applied Genetic Technologies (AGTC)

H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Applied Genetic Technologies today and set a price target of $8. The company’s shares closed yesterday at $4.30.

Pantginis commented:

“Valuation and risks to price target achievement. We maintain our Buy rating and $8 price target. Our valuation is based on our clinical net present value (NPV) model, which allows us to flex multiple assumptions affecting a drug’s potential commercial profile. Factors which could impede reaching our price target include failed or inconclusive clinical trials or inability of the company to secure adequate funding to progress its drugs through the development pathway. Applied Genetic Technologies Corp.”

According to TipRanks.com, Pantginis has 0 stars on 0-5 star ranking scale with an average return of -8.8% and a 35.4% success rate. Pantginis covers the Healthcare sector, focusing on stocks such as SELLAS Life Sciences Group Inc, Iovance Biotherapeutics Inc, and Checkpoint Therapeutics Inc.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Applied Genetic Technologies with a $6.50 average price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts